Galderma deprioritizes study for IL-31 drug; UCB stops work in rare encephalitis

Plus, news about GlycoMimetics and Indivior:

Galderma stops plans to develop nemolizumab in Phase 2: The Swiss dermatology company said it …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

Proton Pump Inhibitors Linked to Serious Infection Risk in Children

Proton pump inhibitors (PPIs) were strongly linked with serious infection risk among infants and young children in a large national study, suggesting caution in prescribing.

August 15, 2023

Opinion | Do Your Patients Know Where You Live?

Casey is a physician assistant. I know where my former therapist lives. There’s no non-creepy way to say that, and that’s precisely the point. The

February 15, 2024

Pharmaceutical Packaging Machines and Labelling Companies

Reliable packaging machines are essential to ensuring pharmaceutical products are packaged safely and efficiently for distribution to consumers. Packaging plays a key role in the

September 20, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.